KonstantinosLeventakosMD

Physician

Dr. Leventakos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2017
MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 2011 - 2014
University of Crete School of Health SciencesClass of 2005

Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer Start of enrollment: 2018 Jun 15
Active, not recruiting
Not Applicable
Roles: Contact, Principal Investigator

PubMed

Evolving Field of Immunotherapy: Pioneering New Paths in Small-Cell Lung Cancer.
Antonious Ziad Hazim, Konstantinos Leventakos, Vinicius Ernani
JCO Oncology Practice. 2025-02-03
Targeted therapy‑associated cardiotoxicity in patients with stage‑IV lung cancer with or without cardiac comorbidities.
Yanmei Peng, Dong Li, Jason A Wampfler, Yung-Hung Luo, Ashok V Kumar
Oncology Reports. 2025-02-01
Emerging Targeted Therapies in Non-Small-Cell Lung Cancer (NSCLC).
Syeda A Mina, Mohamed Shanshal, Konstantinos Leventakos, Kaushal Parikh
Cancers. 2025-01-22

Mayo Clinic Investigator Discusses Remaining Questions on AstraZeneca’s PACIFIC Clinical Trial in Lung CancerAugust 28th, 2019
OncLive® Presents State of the Science Summit™ on Lung CancerAugust 1st, 2019